Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2ND dist. Center, at this point I didn’t think it’s more than just a thought at this point. It would help with speed and shipping cost I hard to say if it would play for itself after all is factored. As you mentioned, volume is needed.
Then we have the right sizing.
From the CC "Our goal of achieving cash flow positive by the end of 2022 is very doable. Achieving cash flow positive and fixing some of our structural issues will allow us to actively participate in the contraction and consolidation of the CBD industry, which we continue to do with our adviser"
Keep words in there " contraction and consolidation of the CBD industry".
For clarity here, regarding the concrete tactic mentioned in your post, are you referring to the wellness line of products, going with the heavy hitting top sellers, or rightsizing. I suppose you could be referring to new product development as well. Regardless if it’s one or all the above they will have to get the marketing down right.
You could be right, who’s to say. I don’t think anything has been priced in yet, mainly because we don’t know what they will be doing and the share price is still in search for a level.
They could break even but I can’t assume that’s a yes. As I wrote before we have a tough year coming up.
I think they can find away to come up with a million if they need to. And I do think they will need to.
The dilution of whatever percent a person chooses can only be a guess at this point. And again, I’m not sure what they are exactly doing. We’ll see.
Again, I’m not sure what they’re up to. What the plan is, as far as the CC, no more carrots for me.
Read the board today, delusional thoughts mixed with make believe seems to be the message of the day. Were beyond just kidding your self here. No need to go over the CC or the filings. The dilution to come should knock this down to .02 or there abouts.
The only question I have is with management. Are they so far over their head, are they just incompetent or are they setting up to go private?
We shall see. IMO
At the end of the day, you can’t have SG&A run higher than the revenue you bring in. Even if the cost of the product has free, you still have a loss. Not much to discuss until that gets corrected. Unless of course you want to talk about losses.
You are right, they have been. They currently have votes to pass it { enough on board} but to your statement Chuck is still trying for a complete package. We'll see.
The last time I was here, about a year ago, they just went to the cap market. It’s spiked over 5 and I hoped everybody got out ok.
Today I read 100 million to be offered. I would think the smart way to play it is wait for the dilution to cook the price down, and then if you think it’s still a good play, buy some at the discounted price.
I think you have time to get into this one, but to each their own.
I think they are about due, to push this thru.
https://www.marijuanamoment.net/congressman-says-theres-tremendous-momentum-to-pass-marijuana-banking-in-bicameral-conference-on-manufacturing-bill/
We'll see. Maybe they will get it thru this time.
https://www.marijuanamoment.net/congressman-says-theres-tremendous-momentum-to-pass-marijuana-banking-in-bicameral-conference-on-manufacturing-bill/
The -.61 a share seems to be a big miss. I wait for the filing to firm that up but I was expecting better.
Charlotte's Web Holdings GAAP EPS of -$0.06 misses by $0.01, revenue of $19.36M misses by $6.16M
May 16, 2022 4:15 PM ETCharlotte's Web Holdings, Inc. (CWBHF)By: Anuron Mitra, SA News Editor1 Comment
Charlotte's Web Holdings press release (OTCQX:CWBHF): Q1 GAAP EPS of -$0.06 misses by $0.01.
Revenue of $19.36M (-17.3% Y/Y) misses by $6.16M.
Thats a big miss. They knew about that in Jan. No mention of it from the previous CC in March . No pre warning- They get what they get in the morning.
The numbers are one thing, the actions are a 2nd. And the words are 3rd. I'm going to listen for the the words in the CC, and then go thru the filings. I want the whole picture before I say anything.
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the quarter ended March 31, 2022.
First Quarter 2022 and Recent Financial and Operating Highlights
Revenue of $4.4 million for first quarter of 2022, compared to $4.8 million for the first quarter of 2021; Gross margin of 26.0% for first quarter of 2022, compared to 32.4% for the fourth quarter of 2021; Total cash balance of $2.4 million at quarter end, compared to $1.4 million at year end; Launched four unique Over-the-Counter (OTC) pain relief topical products formulated to pinpoint sources of minor pain and aches using active ingredients including camphor and menthol along with premium hemp-derived CBD; Launched PlusCBDTM Relief softgels to our wellness line of CBD products joining our successful PlusCBDTM Sleep and Calm gummies; Continued to evaluate strategic review, including consideration of inbound and outbound merger, sale, acquisition or other options for the Company as a whole or for any business segments; Continued to implement strategic cost savings initiatives; Completed new lease agreement of approximately 6,000 square feet for the Company's main facility in San Diego; and Claimed refundable employee retention credit (ERC) under the CARES Act of $2.0 million.
Columbia Care GAAP EPS of -$0.07 in-line, revenue of $123M misses by $14.75M
May 16, 2022 7:05 AM ETColumbia Care Inc. (CCHWF)By: Urvi Shah, SA News Editor2 Comments
Columbia Care press release (OTCQX:CCHWF): Q1 GAAP EPS of -$0.07 in-line.
Revenue of $123M (+33.0% Y/Y) misses by $14.75M.
Start with this for a taste. If this suits you ,than move over the stock.charts. com for the next level.
https://ifta.org/wp-content/uploads/2018/05/technicalhandbook_2018_NTAA.pdf
Going over the 10k this morning. Revenues were fine, cash and cash equivalents were fine. Debt and Long-term liabilities, I was hoping for better, they are a little over 1.4 billion.
Year over year we had 125 million more in rev. 43 million gross profit {82 million more in cost of goods} Net went from a plus 30 a year ago to neg. 32 million. And the shares increase 68 million. 1.37 billion of that was for Harvest which we knew about.
Earning per share, rev per share, cash per share and debt per share could all be better.
Now I do understand all the ramifications with the waiting on gov process, the covid issues, and the current market were in, but at the end of the day having high rev. doesn’t mean much if your losing money.
Was it a bad quarter, no. But until they can turn a reasonable profit IMO you can not call it a good one. Again IMO
Down 44.06 percent in May. I guess sell in May and go away is alive and well here. It's a shame really, we still over 1/2 month to go.
I wonder if this is what they mean by letting the weak hands leave? Don't know if it was the weak hands or not but somebody is leaving.
Don't know what the ER/CC will bring but if it's the old same B/S they been working for the last 2 years it would then set up a very poor summer, mixed with what the over all markets are doing, interest rates will be doing and inflation is doing, it will be interesting where this one could be at the end of summer.IMO
Well, I hope you are right. The beauty of it is we don’t have long to wait. I’m going to need more substance than the standard boilerplate, same old same old, we can’t compete, covid is in our way, it’s been tough you understand speak. This is the biggest er/cc that they have had. They should be in a mild state of panic. The stock is a few pennies away form zero. The rig around the shareholders better be carefully explained on the “why’s” of that need. As you correctly pointed out, they’re not the ones who own the company. I need to know what those needs were, and what they will be doing, the stock is at 6 cents, play time is over. IMO
Must have got my end of summer and end of week mixed up.
Big drop today, most of the markets and sector were up. Volume was 900 percent above avg volume, somebody wanted out. Unless they would play a wash, they will be locked out for 30 days. Still not enough, in fact not even close to capitulation. Ever get the feeling somebody knows something you don’t?
Newest projection from just today. Charlotte's Web Holdings (OTCQX:CWBHF) Q1 consensus EPS estimate is -$0.06 and consensus revenue estimate is $26.22M (+12.0% Y/Y).
The new CEO made statements on reducing expenses, and revving up sales and making it simple with what he called the 5 pillars. CW 2.0 he called it. Monday we’ll find out how he’s done.
So, a taste from the last CC.
“So, welcome the CW 2.0. That’s what I said in my first town hall with employees on December 17. I also said it, it was all upside, and I meant it, growing revenues being cash generative and acting with the confidence of the leading brand in CBD, those are our goals. The U.S. CBD market is a multibillion-dollar category. The truth is we haven’t done enough to amplify our brand equity or our unparalleled science credentials with consumers. That is most evident with three data points. Our e-commerce traffic is down by reinforcing our brand equity, we can rely less on promotional pricing. By the way, as does the competitive set, and reengaging the Stanley Brothers in storytelling and innovation, while keeping us grounded in the mission of the company to improve 1 billion lives again and again.
Internally, I believe we overcomplicated our business. And look, that’s all in a rearview mirror. So now let’s look through the windshield to CW 2.0. In my first weeks as CEO, we laid down five pillars that support our priorities for 2022 and our long game, better aligning our leadership team with shareholders, rightsizing our expenses to the size of the current business and being choiceful in the use of cash. We’re bringing back a culture of founders, family and fearless. Growing revenues regardless of regulatory action and simplifying our business with speed and executional excellence.
GO TEAM GO.
Now were hitting some volume.
It will be a interesting ER. I would think over above the last qt results they will have some serious talking on the direction, the rev. split, and adding, say 600 million, just picked one number, and EXACTLY HOW all of that will relate to said direction. They better have a plan and they better explain it well.
Looks like they are projected to only lose .05 cents a share. I would have thought more , we'll see.
Well at least they're getting the volume up.
Looking forward to that 1st qt report and the SEC filing. Should be fun.
I believe I mentioned back in Nov/Dec that .60 by the end og May. I think sub .50 by the end of summer . We'll see. 1st qt earnings coming up.
Ayr Wellness Shares Slide On $37.4 Million Upsized CAPEX Facility From XS Financial
5/9/22 12:03 PM ET (Benzinga)Print
XS Financial Inc. (CSE:XSF)(OTCQB: XSHLF), a specialty finance company providing CAPEX and equipment financing solutions to cannabis companies in the United States, has upsized its lease facility with Ayr Wellness (CSE:AYR.A)(OTCQX: AYRWF) up to $37.4 million including an immediate drawdown of $12 million, bringing the total usage to over $33.1 million.
"Working with the XS team has been a seamless process over the last two years," Brad Asher CFO of AYR Wellness stated. "They are fully integrated as an extension of our procurement and development teams, who have benefitted from their deep industry knowledge in state-of-the-art equipment. We are proud of our long-standing partnership with the XS team and their commitment to achieving our mission of being the largest producer of high-quality cannabis at scale."
David Kivitz, CEO of XS Financial commented: "We are thrilled to expand our relationship with one of our longest-tenured customers as their needs have increased. We work with AYR to provide an equipment financing solution that has flexibility for their business while never charging non-utilization fees. AYR is one of the largest cannabis companies in the U.S., and as their facilities and footprint continue to grow and scale, so do their infrastructure requirements. We expect more requests for large-scale CAPEX from the industry, including cultivation, manufacturing, and processing equipment and will be financing more of these mission-critical items for qualified customers."
I see the ETF’s in this sector are running between 15 and 17 on the RSI. That doesn’t include WEED which hasn’t been around long enough to start a proper RSI. However in roughly 2 weeks they are down roughly 25 percent.
I wonder just how helpful Mitch will be in that regard.
They have the votes to pass safe banking right now. In both the House and Senate. Schumer however wants a broader bill. It should be noted that his latest watered down bill doesn't include safe banking. While that bill is good for a cash grab it doesn't fix or repair the current problems the sector is facing. Until he changes his mind, or it fails we won't be going to where we need to go. IMO
There is alot more to all this but it's all political and in less than 6 mo it will all change again regardless.
Yes it will, I see MSOS is down around 43 percent over the last 6 mo. PSDN is down 65 percent but they have only been around since OCT. Good time to think things thru, see where we are at in 6 mo and 1 yr out.
Yea, I can't walk away from this either. Dow down 1000 points, ETF's are selling off pretty good I'm guessing, unlike a regular investor, they will be buying back at some point. Currently I now have 30k even in shares. 14.91 avg. Once it gets over 33 plus my thought may go to selling some, but there is no question that it will get there, 6mo ,a year doesn't matter. I have the time.
Not a fun day. However still buying today. I'll get it at these prices and then figure how I want to play. At this point I'm convinced it's the ETF's causing the pain.
Another to mention would be wait for the wedge break.
That being said, I didn't wait, went with the RSI.
Still believe the drop is related to the ETF's. No proof to present however.
I’ve been buying this week. Well, was buying last week too. I’m over on the shares total that I thought I would have {my overall avg is 15.25 on 24k in shares.}. And I’m happy with it. One of the other ones I hold about equal value in {GTBIF} came out with earnings today. Rock solid qt. I’m holding this one will have the same.
Current rsi is 20. Looking for a hook on the macd. next. For me these are easy buys, just saying.
This bears repeating. Going into this qt I was concerned what effect inflation and pricing would have on the numbers. EBITDA is very good. with all considered.
This was a very solid qt.
"EBITDA for the first quarter 2022 was $77.5 million or 32% of revenue compared to $66.5 million or 34% of revenue for the same period in the prior year. Adjusted Operating EBITDA, which excluded non-cash stock-based compensation of $4.7 million and $15.2 million of other non-operating income, was $67.0 million or 28% of revenue as compared to $71.4 million or 37% of revenue in the comparable period. The decrease in Adjusted Operating EBITDA largely reflected inflation on raw material inputs and additional compensation for talent throughout the organization. The Company continues to invest in its infrastructure to prepare for future demand in key markets. The decrease also reflected pricing headwinds in Pennsylvania, Nevada and Massachusetts "
It's what we need - Green Thumb Industries Profit Nearly Triples, Powering Past Estimate -- MarketWatch
4:13 pm ET May 4, 2022 (MarketWatch)
Print
Green Thumb Industries Inc. said Wednesday its first-quarter earnings rose to $28.9 million or 12 cents a share, from $10.4 million, or 5 cents a share in the year-ago quarter. Revenue at the cannabis company increased 25% to $242.6 million from $194.4 million in the year-ago period as it opened 20 new stores and ended the quarter with 76 retail stores. Wall Street analysts expected Green Thumb Industries to earn 6 cents a share on revenue of $237.6 million, according to FactSet data. Green Thumb said the three months ended March 31st marked its seventh consecutive quarter of positive net income. "As I have said before, growth is not linear and there will be quarter-to-quarter fluctuations depending on when new markets open to adult-use sales as well as the timing of our infrastructure investments," CEO Ben Kovler said. Shares of Green Thumb Industries are down 41.6% in 2022, compared to a decline of 41.7% percent by the AdvisorShares Pure US Cannabis ETF (MSOS) and a drop of 17.1% by the Nasdaq .
I'll take it! - Green Thumb Industries Reports First Quarter 2022 Financial Results
MAY 4, 2022
CHICAGO and VANCOUVER, British Columbia, May 04, 2022 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE dispensaries, today reported its financial results for the first quarter ended March 31, 2022. Financial results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and all currency is in U.S. dollars.
Highlights for the first quarter ended March 31, 2022:
Revenue increased 25% year-over-year to $243 million, flat compared to the fourth quarter of 2021
Seventh consecutive quarter of positive GAAP net income, delivering $29 million or $0.12 per basic and diluted share
Adjusted Operating EBITDA was $67 million or 28% of revenue
Ninth consecutive quarter of positive cash flow from operations, generating $55 million in the first quarter
Cash at quarter end totaled $175 million
Subsequent to quarter end, New Jersey’s Cannabis Regulatory Commission approved seven medical marijuana operators, including Green Thumb, to begin selling adult-use cannabis on April 21; RISE Bloomfield and RISE Paterson were among the first stores to begin adult-use sales on Day One.
See definitions and reconciliation of non-GAAP measures elsewhere in this release.
Management Commentary
“Our team delivered solid first quarter results with revenue increasing 25% over the prior year quarter. We generated our seventh consecutive quarter of positive net income of $29 million, or $0.12 per share, and Adjusted Operating EBITDA of $67 million. For the ninth consecutive quarter, we delivered positive cash flow from operations, which was $55 million in the first quarter,” said Green Thumb Founder and Chief Executive Officer Ben Kovler. “We continue to have strong conviction in our core thesis and given the opportunity ahead, we will invest in markets where we know demand is coming. As I have said before, growth is not linear and there will be quarter-to-quarter fluctuations depending on when new markets open to adult-use sales as well as the timing of our infrastructure investments. Our preparations in New Jersey positioned us well for demand on Day One, and we feel confident in our playbook for future adult-use transitions.”
“We believe that all our markets will eventually open to adult-use sales—we don’t know exactly when—but we do know that Americans are choosing cannabis for well-being and our trusted family of brands are well-positioned for the future. There is tremendous opportunity in this Great American Growth story, and we believe that the approximately $25 billion legal U.S. cannabis market will have significant growth over the next decade,” concluded Kovler.
First Quarter 2022 Financial Review
Total revenue increased 25% to $242.6 million from $194.4 million in the prior year period, driven by contributions from both the Retail and Consumer Packaged Goods businesses. On a sequential basis, revenue was essentially flat compared to $243.6 million in the fourth quarter 2021. Year-over-year revenue growth was driven by expanded distribution of Green Thumb’s branded products, 20 new stores and increased traffic in the Company’s 76 retail stores open and operating at quarter end.
All 15 of Green Thumb’s state markets contributed to first quarter revenue: California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia. The Company also continued to invest in the expansion of its cultivation and manufacturing capabilities across its footprint.
Gross profit for the first quarter 2022 was $122.9 million or 51% of revenue compared to $110.9 million or 57% of revenue for the comparable period.
Total selling, general and administrative expenses for the first quarter were $68.4 million or 28% of revenue, compared to $59.3 million or 31% of revenue for the first quarter 2021. Improved operating costs as a percentage of revenue reflected increased operating leverage.
Net income attributable to the Company for the first quarter 2022 was $28.9 million or $0.12 per basic and diluted share, compared to net income of $10.4 million, or $0.05 per basic and diluted share in the prior year.
EBITDA for the first quarter 2022 was $77.5 million or 32% of revenue compared to $66.5 million or 34% of revenue for the same period in the prior year. Adjusted Operating EBITDA, which excluded non-cash stock-based compensation of $4.7 million and $15.2 million of other non-operating income, was $67.0 million or 28% of revenue as compared to $71.4 million or 37% of revenue in the comparable period. The decrease in Adjusted Operating EBITDA largely reflected inflation on raw material inputs and additional compensation for talent throughout the organization. The Company continues to invest in its infrastructure to prepare for future demand in key markets. The decrease also reflected pricing headwinds in Pennsylvania, Nevada and Massachusetts.
For additional information on these non-GAAP financial measures, see below under “Non-GAAP Financial Information.”
I think many are surprised on the depth of this drop, it’s a little over done. No, I don’t think you are missing anything that isn’t already out there. The sector is still very much in a bear market, and were in the sector. Many are showing the same direction, same drops. The lack of bills being passed, and indirectly the inflation concerns, interest concern, the overall economy and soon the election issues have everybody off balance with their thought processes.
The company is in good shape and seem to be doing all the right things they need to do. No, this is all macro.
Well here we are, under 7. Today sellers out number buyers more than 3 to 1. I was a buyer today, seems like very good value, but we'll see I guess.
Lighter trading volume the last two days. Sellers out number buyers two to 1. Earnings will be coming up, maybe that will increase the interest.